NIH, GreenLight Biosciences to collaborate on COVID-19 vaccine development for new variants Read more
Novartis and UC Berkeley Extend Alliance to Tackle ‘Undruggable’ Disease Targets and Discover New Therapeutic Modalities Read more
Melinta Therapeutics and Cidara Therapeutics Announce Licensing Agreement to Commercialize Rezafungin in the U.S. Read more
Novavax Announces Expanded Approval of Nuvaxovid COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan Read more
European Commission Approves RINVOQ (upadacitinib) for the Treatment of Adults With Moderate to Severe Ulcerative Colitis Read more
Ionis announces that FDA accepts New Drug Application and grants Priority Review of tofersen for a rare, genetic form of ALS Read more
Enhertu granted Priority Review in the US for patients with HER2-low metastatic breast cancer Read more
Bavarian Nordic Receives European Approval of Extension of Vaccine Label to Include Monkeypox Read more
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA Read more